ICD-10-PCS code structure

Section:
  X = New Technology

Body System:
  W = Anatomical Regions

Root Operation:
  0 = Introduction

Body Part:


See Terms used in New Technology

Select the appropriate procedure code based on the approach & device:

XW04 - Central Vein

  • Percutaneous Approach

    Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure

    • Spesolimab Monoclonal Antibody
      • XW04306 - Introduce Brexanolone in Central Vein, Perc, New Tech 6
      • XW04308 - Introduce Spesolimab in Central Vein, Perc, New Tech 8
    • Anacaulase-bcdb
      • XW04326 - Introduce Nerinitide in Central Vein, Perc, New Tech 6
    • Maribavir Anti-infective
      • XW04336 - Introduce Durvalumab in Central Vein, Perc, New Tech 6
    • Narsoplimab Monoclonal Antibody
      • XW04357 - Introduce Narsoplimab in Central Vein, Perc, New Tech 7
      • XW04358 - Introduce Mosunetuzumab in Central Vein, Perc, New Tech 8
    • Terlipressin
      • XW04366 - Introduce Lefamulin in Central Vein, Perc, New Tech 6
      • XW04367 - Introduce Terlipressin in Central Vein, Perc, New Tech 7
      • XW04368 - Introduce Afamitresgene in Central Vein, Perc, New Tech 8
    • Coagulation Factor Xa, Inactivated
      • XW04372 - Introduce Coag Factor Xa in Central Vein, Perc, New Tech 2
      • XW04377 - Introduce Trilaciclib in Central Vein, Perc, New Tech 7
      • XW04378 - Introduce Tabelecleucel in Central Vein, Perc, New Tech 8
    • Treosulfan
      • XW04387 - Introduce Lurbinectedin in Central Vein, Perc, New Tech 7
      • XW04388 - Introduce Treosulfan in Central Vein, Perc, New Tech 8
    • Satralizumab-mwge
      • XW04396 - Introduce Ceftoloz/Tazobac in Central Vein, Perc, New Tech 6
      • XW04398 - Introduce Inebilizumab in Central Vein, Perc, New Tech 8
    • Ciltacabtagene Autoleucel
      • XW043A6 - Introduce Cefiderocol in Central Vein, Perc, New Tech 6
      • XW043A7 - Introduce Ciltacab in Central Vein, Perc, New Tech 7
    • Omadacycline Anti-infective
      • XW043B3 - Introduce cytarab/daunorub in Central Vein, Perc, New Tech 3
      • XW043B6 - Introduce Omadacycline in Central Vein, Perc, New Tech 6
      • XW043B7 - Introduce Amivantamab in Central Vein, Perc, New Tech 7
    • Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
      • XW043C6 - Introduce Eculizumab in Central Vein, Perc, New Tech 6
      • XW043C7 - Introduce Autolog CAR T in Central Vein, Perc, New Tech 7
    • Engineered Allogeneic Thymus Tissue
      • XW043D6 - Introduce Atezolizumab in Central Vein, Perc, New Tech 6
    • Etesevimab Monoclonal Antibody
      • XW043E5 - Introduce Remdesivir in Central Vein, Perc, New Tech 5
      • XW043E6 - Introduce Etesevimab in Central Vein, Perc, New Tech 6
    • Other New Technology Therapeutic Substance
      • XW043F3 - Introduce New Tech Therap in Central Vein, Perc, New Tech 3
      • XW043F5 - Introduce New Tech Therap in Central Vein, Perc, New Tech 5
      • XW043F6 - Introduce Bamlanivimab in Central Vein, Perc, New Tech 6
    • Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
      • XW043G5 - Introduce Sarilumab in Central Vein, Perc, New Tech 5
      • XW043G6 - Introduce REGN-COV2 in Central Vein, Perc, New Tech 6
      • XW043G7 - Introduce Allogen CAR T in Central Vein, Perc, New Tech 7
    • Axicabtagene Ciloleucel Immunotherapy
      • XW043H5 - Introduce Tocilizumab in Central Vein, Perc, New Tech 5
      • XW043H6 - Introduce Monclon Antib in Central Vein, Perc, New Tech 6
      • XW043H7 - Introduce Axicab in Central Vein, Perc, New Tech 7
    • Apalutamide Antineoplastic
      • XW043J7 - Introduce Tisagen in Central Vein, Perc, New Tech 7
    • Idecabtagene Vicleucel Immunotherapy
      • XW043K5 - Introduce Fosfomycin in Central Vein, Perc, New Tech 5
      • XW043K7 - Introduce Ide-cel in Central Vein, Perc, New Tech 7
    • Erdafitinib Antineoplastic
      • XW043L6 - Introduce CD24Fc in Central Vein, Perc, New Tech 6
      • XW043L7 - Introduce Lifileucel in Central Vein, Perc, New Tech 7
    • Baricitinib
      • XW043M7 - Introduce Brexucab in Central Vein, Perc, New Tech 7
    • Lisocabtagene Maraleucel Immunotherapy
      • XW043N5 - Introduce Merop-vaborbct in Central Vein, Perc, New Tech 5
      • XW043N7 - Introduce Lisocab in Central Vein, Perc, New Tech 7
    • Tagraxofusp-erzs Antineoplastic
      • XW043Q5 - Introduce Tagraxofusp-erzs in Central Vein, Perc, New Tech 5
    • Epcoritamab Monoclonal Antibody
      • XW043S5 - Introduce Iobenguane I-131 in Central Vein, Perc, New Tech 5
    • COVID-19 Vaccine
      • XW043U5 - Introduce IMI/REL in Central Vein, Perc, New Tech 5
    • Caplacizumab
      • XW043W5 - Introduce Caplacizumab in Central Vein, Perc, New Tech 5